Search results for "lung cancer"

showing 10 items of 508 documents

Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): A multicentre phase II clinical trial

2001

Abstract A phase II study in patients with stage IIIB/IV non-small cell lung cancer (NSCLC) was carried out to evaluate the clinical activity and toxicity of the chemotherapeutic combination of gemcitabine+vinorelbine (GEM/VNR). Forty-five patients (40 male, 5 female) with a median age of 67 years (range 37–73) and a median ECOG performance status of 1 (range 0–2) were enrolled into the trial. Twenty patients had stage IIIB (two positive supraclavicular nodes and 20 cytologically positive pleural effusion), and 25 had stage IV NSCLC. GEM 1000 mg/m 2 diluted in 250 cc 3 of normal saline was administered iv on days 1, 8, and 15, while VNR was given 30 mg/m 2 on days 1 and 8 every 4 weeks. The…

Pulmonary and Respiratory MedicineAdultMaleCancer Researchmedicine.medical_specialtyLung NeoplasmsNeutropeniaPleural effusionmedicine.drug_classnon-small cell lung cancer (NSCLC)Phases of clinical researchNeutropeniaVinorelbineVinblastineGastroenterologyAntimetaboliteDeoxycytidineInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansInfusions IntravenousAgedbusiness.industryVinorelbineMiddle Agedmedicine.diseaseSurvival AnalysisGemcitabineGemcitabineSurgeryRegimenTreatment OutcomeOncologyInjections IntravenousFemalebusinessmedicine.drug
researchProduct

Oxidative lung injury correlates with one-lung ventilation time during pulmonary lobectomy: a study of exhaled breath condensate and blood.

2015

OBJECTIVES: During lung lobectomy, the operated lung is collapsed and hypoperfused; oxygen deprivation is accompanied by reactive hypoxic pulmonary vasoconstriction. After lung lobectomy, ischaemia present in the collapsed state is followed by expansion–reperfusion and lung injury attributed to the production of reactive oxygen species. The primary objective of this study was to investigate the time course of several markers of oxidative stress simultaneously in exhaled breath condensate and blood and to determine the relationship between oxidative stress and one-lung ventilation time in patients undergoing lung lobectomy. METHODS: This single-centre, observational, prospective study includ…

Pulmonary and Respiratory MedicineAdultMaleVentilator-Induced Lung InjuryIschemiaLung injuryDinoprostHypoxic pulmonary vasoconstrictionmedicineHumansExhaled breath condensateProspective StudiesLung cancerProspective cohort studyPneumonectomyNitritesAgedAged 80 and overLungNitratesbusiness.industryGeneral MedicineHydrogen Peroxiderespiratory systemMiddle Agedmedicine.diseaserespiratory tract diseasesOne-Lung VentilationOxidative Stressmedicine.anatomical_structureBreath TestsAnesthesiaReperfusion InjuryBreathingSurgeryFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study.

2007

Introduction This study's aim was to assess economic data regarding the home assistance burden for advanced non-small cell lung cancer (NSCLC) patients in Italy. Patients and Methods One hundred four NSCLC patients in second-line chemotherapy (2LC) or in supportive therapy (ST) were enrolled in 18 Italian oncology departments and were observed for 3 months. The main caregiver's workload was assessed monthly by a task scale; other caregivers' activities were also registered. Eastern Cooperative Oncology Group performance status was assessed by physicians, and patients completed the Lung Cancer Symptoms (LCS) subscale. Formal caregiving time was valued according to market prices; informal car…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyLung NeoplasmsHome Nursingmedia_common.quotation_subjectAntineoplastic Agentscaregiving burden in advanced non-small cell lung cancerNSCLCQuality of lifeCost of IllnessCarcinoma Non-Small-Cell LungmedicineHumansLung cancermedia_commonAgedAged 80 and overbusiness.industrySocial SupportWorkloadAssistance burdenHealth Care CostsMiddle Agedmedicine.diseaseOncologyCaregiversItalySocioeconomic FactorsInformal caregivingSpouseSupportive psychotherapyScale (social sciences)Family medicinePhysical therapyCosts and Cost AnalysisQuality of LifeFemaleHabitNon small cellbusiness
researchProduct

Mediastinal lymph node staging with transesophageal echography in cancer of the lung.

1990

Transesophageal echography (TEE) was used prospectively to study mediastinal lymph node enlargement in 23 patients with cancer of the lung. The findings were validated blindly by comparison with computed tomography (CT, n = 23) and pathological N classification after curative surgery (n = 9). Lymph nodes larger than 1 cm were defined as pathologically enlarged. In the upper mediastinum, 22% (8 vs 36), in the lower mediastinum including the subaortic region 112% (37 vs 33) and in the hilar region 67% (6 vs 9) of enlarged lymph nodes diagnosed by CT were detected by TEE. A pathological study in 9 patients demonstrated true positive findings in 2 vs 1, true negatives in 4 vs 5, false positives…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyLung NeoplasmsSensitivity and SpecificityAortopulmonary windowEsophagusBronchoscopymedicineCarcinomaHumansProspective StudiesLung cancerAgedNeoplasm StagingUltrasonographyLungbusiness.industryBiopsy NeedleMediastinumGeneral MedicineMiddle Agedmedicine.diseasemedicine.anatomical_structureGreat vesselsEvaluation Studies as TopicMediastinal lymph nodeLymphatic MetastasisSurgeryFemaleRadiologyLymphCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

The use of video-assisted thoracic surgery in the management of Pancoast tumours

2010

We describe our experience using video-assisted thoracic surgery (VATS) as an adjunct to the surgical management of Pancoast tumors. Between March 2004 and November 2009, 13 patients with Pancoast tumors were included in this study. Surgery was performed by positioning the patient to allow either an anterior or a posterior thoracotomy. VATS was employed to explore the pleural cavity, to optimize the surgical access and as an assistance during surgical resection. Three patients with pleural carcinosis at thoracoscopy did not undergo further surgery. Seven lobectomies and three wedge resections were performed with an en bloc chest-wall resection and mediastinal lymphadenectomy. The surgical a…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyTime FactorsCarcinosismedicine.medical_treatmentBlood Loss SurgicalGeneral thoracic surgerySuperior sulcus tumorsPatient PositioningGeneral thoracic surgery; Lung cancer; Superior sulcus tumorsPancoast tumorPneumonectomymedicineThoracoscopyHumansThoracotomyPneumonectomyAgedmedicine.diagnostic_testbusiness.industryThoracic Surgery Video-AssistedMediastinumPancoast SyndromePleural cavityLength of StayMiddle Agedmedicine.diseaseNeoadjuvant TherapySurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureTreatment OutcomeItalyThoracotomyCardiothoracic surgeryChemotherapy AdjuvantLymph Node ExcisionSurgeryFemaleRadiotherapy AdjuvantRadiologyLung cancerCardiology and Cardiovascular Medicinebusiness
researchProduct

A comparative analysis of Pancoast tumour resection performed via video-assisted thoracic surgery versus standard open approaches.

2014

OBJECTIVES: The aim of the present paper was to conduct a comparative analysis of outcomes after thoracoscopic resection versus standard thoracotomy approach in the treatment of Pancoast tumours. METHODS: All consecutive patients with Pancoast tumours undergoing surgical treatment from March 2000 to November 2012 were enrolled. Patients were divided into 2 groups according to whether a thoracoscopic or standard thoracotomy approach was adopted. In addition to morbidity and mortality, (i) intensity of pain; (ii) respiratory function focusing on the postoperative value and its variation with respect to the predicted value (Delta); (iii) analgesic consumption at different times during the post…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyVital capacityTime Factorsmedicine.medical_treatmentSettore MED/21 - Chirurgia ToracicaKaplan-Meier EstimatePreoperative carePancoast tumour; Superior sulcus tumour; Video-assisted thoracoscopic resection; Surgery; ThoracotomyPancoast tumorRisk FactorsmedicineHumansRespiratory functionNeoplasm InvasivenessThoracotomyLung cancerPneumonectomySurvival rateAgedNeoplasm StagingPain MeasurementRetrospective StudiesAnalgesicsPain Postoperativebusiness.industryThoracic Surgery Video-AssistedSuperior sulcus tumourPancoast SyndromeRecovery of FunctionPleural cavityMiddle Agedmedicine.diseaseSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureTreatment OutcomeItalyThoracotomyAnesthesiaPancoast tumourVideo-assisted thoracoscopic resectionSurgeryFemaleLung cancerCardiology and Cardiovascular MedicinebusinessInteractive cardiovascular and thoracic surgery
researchProduct

The role of mucin 1 in respiratory diseases

2020

Recent evidence has demonstrated that mucin 1 (MUC1) is involved in many pathological processes that occur in the lung. MUC1 is a transmembrane protein mainly expressed by epithelial and hematopoietic cells. It has a receptor-like structure, which can sense the external environment and activate intracellular signal transduction pathways through its cytoplasmic domain. The extracellular domain of MUC1 can be released to the external environment, thus acting as a decoy barrier to mucosal pathogens, as well as serving as a serum biomarker for the diagnosis and prognosis of several respiratory diseases such as lung cancer and interstitial lung diseases. Furthermore, bioactivated MUC1-cytoplasmi…

Pulmonary and Respiratory MedicineAnti-Inflammatory Agents03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicinePulmonary fibrosismedicineAnimalsHumansRespiratory systemLung cancerMUC1lcsh:RC705-779Lungbusiness.industryMucinMucin-1lcsh:Diseases of the respiratory systemmedicine.diseaseAsthmaIntracellular signal transductionBiomarkermedicine.anatomical_structure030228 respiratory system030220 oncology & carcinogenesisCancer researchbusinessSignal Transduction
researchProduct

Bcl-2, Bcl-xl, and pp32/PHAPI in resected non-small-cell lung cancer patients

2009

Einleitung: Fur viele Tumorarten ist der Einfluss des Apoptosesignalweges auf die Prognose der Tumorerkrankung beschrieben worden. So konnte fur die antiapoptotischen Proteine wie Bcl-2 und Bcl-xL gezeigt werden, dass sie den mitochondrialen Selbstzerstorungsmechanismus der Zellen herunterregulieren konnen. Fur nicht-kleinzellige Lungenkarzinomen (NSCLC) hingegen existieren widerspruchliche Angaben in der wissenschaftlichen Literatur in Bezug auf die prognostische Wertigkeit apoptotischer und insbesondere antiapoptotischer Faktoren. Ein weiterer wichtiger Faktor im genannten Mechanismus, welches NSCLC fur apoptotische Stimuli sensibilisieren soll, ist das Protein pp32/PHAPI. Fur bereits che…

Pulmonary and Respiratory MedicineBcl 2 bcl xlbusiness.industryCancer researchMedicineNon small cellbusinessLung cancermedicine.diseaseMolecular biologyPneumologie
researchProduct

Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung…

2015

8073 Background: Afatinib 40 mg/day (oral) is approved for the treatment of pts with advanced EGFRm+ NSCLC. Dose adjustment is recommended according to pre-defined tolerability criteria. We perform...

Pulmonary and Respiratory MedicineBrachial Plexus NeuritisOncologyCancer Researchmedicine.medical_specialtybusiness.industryAfatinibMedizinnon-small cell lung cancer (NSCLC)HematologyPharmacologymedicine.diseasestomatognathic diseasesTolerabilityOncologyEgfr mutationDose adjustmentInternal medicinemedicineIn patientbusinessmedicine.drug
researchProduct

Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers.

2005

T lymphocytes modulate the pulmonary inflammatory response. The aim of this study was to evaluate the clonality within the interstitial lung and peripheral blood T cell receptor (TCR) repertoire in smokers. Interstitial T lymphocytes were isolated from surplus tissue of 16 patients (63 +/- 9 [+/- SD] yr old, 11 male) undergoing surgery due to lung cancer (n = 15) or emphysema. TCR clonality was assessed by PCR amplification followed by spectratyping. Nearly all TCR of interstitial lung lymphocytes showed oligoclonal bands (CD4(+) subset 13/16 patients, 81%; CD8(+) 100%) indicating a specific differentiation. Peripheral blood T lymphocytes (PBL) TCR (especially CD4(+)) had less oligoclonal b…

Pulmonary and Respiratory MedicineCD4-Positive T-LymphocytesMalePathologymedicine.medical_specialtyLung NeoplasmsCellular differentiationClinical BiochemistryReceptors Antigen T-Cellchemical and pharmacologic phenomenaBiologyCD8-Positive T-LymphocytesPolymerase Chain ReactionmedicineHumansIntraindividual comparisonCell LineageLung cancerMolecular BiologyLungAgedLungT-cell receptorSmokinghemic and immune systemsCell DifferentiationCell BiologyMiddle Agedmedicine.diseasePeripheral bloodT-Cell Receptor Repertoiremedicine.anatomical_structureBloodPulmonary EmphysemaFemaleCD8American journal of respiratory cell and molecular biology
researchProduct